Drug Trial Radar · NCT04720157
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,144
Actual
Start
Jun 9, 2021
Primary completion
Jan 13, 2025
Study completion Aug 1, 2028
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- Collaborators
- Alliance Foundation Trials, LLC.; RTOG Foundation, Inc.
- First posted
- Jan 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male patients with Metastatic hormone sensitive prostate cancer (mHSPC). In this study, the SoC is defined as a combination of Androgen Receptor Directed Therapy (ARDT) + Androgen Deprivation Therapy (ADT). Approximately 1126 patients will be randomized in this study. As of 31-Jan-2024, 1144 participants were enrolled in 19 countries.
Conditions
- Prostatic Neoplasms
Interventions
177Lu-PSMA-617Drug
administered intravenously once every 6 weeks (1 cycle) for 6 cycles
68Ga-PSMA-11Drug
Intravenous dose of approx. 150 Megabecquerel (MBq) at screening and at time of centrally confirmed rPD
ARDTDrug
Administered orally on a continuous basis as per package insert and guideline
ADTDrug
ADT are administered as per physician order
Primary outcomes
What the sponsor says the trial is designed to measure.
- Radiographic Progression Free Survival (rPFS)Time frame: From date of randomization until date of radiographic progression or date of death from any cause, whichever comes first, assessed up to approx 43 months
Locations
164 sites in 19 countries. Site status is shown where the registry gives one.
Mayo Clinic Arizona
Scottsdale, Arizona
University of California San Diego - Moores Cancer Center
La Jolla, California
VA Greater LA Healthcare System
Los Angeles, California
University of California LA
Los Angeles, California
St. Joseph Hospital
Orange, California
Univ Cali Irvine ALS Neuromuscular
Orange, California
VA Palo Alto Health Care System
Palo Alto, California
Stanford University Medical Center
Palo Alto, California
Sansum Clinic
Santa Barbara, California
Providence Saint Johns Health Ctr
Santa Monica, California
Univ Of Color Anschutz Med Center
Aurora, Colorado
Rocky Mountain Cancer Centers
Denver, Colorado
Hartford Hospital
Hartford, Connecticut
Georgetown University-Lombardi Cancer Center
Washington D.C., District of Columbia
VA Medical Center
Washington D.C., District of Columbia
Mayo Clinic Jacksonville
Jacksonville, Florida
Cancer Specialists of North Florida
Jacksonville, Florida
University Of Miami
Miami, Florida
Baptist Health South
Miami, Florida
Florida Cancer Affiliates
Panama City, Florida
University Cancer and Blood Center LLC
Athens, Georgia
The Queens Medical Centre
Honolulu, Hawaii
Northwestern University
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Chicago
Chicago, Illinois
Hines VA Hospital
Hines, Illinois
Parkview Research Center
Fort Wayne, Indiana
Indiana University
Indianapolis, Indiana
Tulane Cancer Center
New Orleans, Louisiana
Ochsner Clinic Foundation
New Orleans, Louisiana
Sidney Kimmel CCC At JH
Baltimore, Maryland
Dana Farber Cancer Institute
Boston, Massachusetts
Uni Of Michigan Health System
Ann Arbor, Michigan
Corewell Health William Beaum Hosp
Royal Oak, Michigan
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic Rochester
Rochester, Minnesota
University of Mississippi Med Ctr
Jackson, Mississippi
St Louis University
St Louis, Missouri
VA St Louis Health Care System
St Louis, Missouri
Wash U School of Medicine
St Louis, Missouri
Showing 40 of 164 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.